<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">9918750589006676</journal-id><journal-id journal-id-type="pubmed-jr-id">53093</journal-id><journal-id journal-id-type="nlm-ta">Subst Use Addctn J</journal-id><journal-id journal-id-type="iso-abbrev">Subst Use Addctn J</journal-id><journal-title-group><journal-title>Substance use &#x00026; addiction journal</journal-title></journal-title-group><issn pub-type="ppub">2976-7342</issn><issn pub-type="epub">2976-7350</issn></journal-meta><article-meta><article-id pub-id-type="pmid">39096200</article-id><article-id pub-id-type="pmc">11789002</article-id><article-id pub-id-type="doi">10.1177/29767342241267086</article-id><article-id pub-id-type="manuscript">HHSPA2032263</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Identifying patients at risk for alcohol-exposed pregnancies: The
importance of addressing multiple risk factors</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>McRee</surname><given-names>Bonnie G.</given-names></name><degrees>PhD, MPH</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Hanson</surname><given-names>Bridget L.</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Vendetti</surname><given-names>Janice</given-names></name><degrees>MPH</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>King</surname><given-names>Diane K.</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Pawlukiewicz</surname><given-names>Iwona</given-names></name><degrees>MPH</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Berry</surname><given-names>Erin</given-names></name><degrees>MD, MPH</degrees><xref rid="A3" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>Jessica</given-names></name><degrees>BSW</degrees><xref rid="A4" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Marshall</surname><given-names>Deanna</given-names></name><degrees>MPH</degrees><xref rid="A3" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Rosato</surname><given-names>Lauren</given-names></name><degrees>IMBA</degrees><xref rid="A4" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Gallucci</surname><given-names>Karen Steinberg</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Whitmore</surname><given-names>Corrie</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>University of Connecticut School of Medicine, Farmington,
CT</aff><aff id="A2"><label>2</label>Center for Behavioral Health Research and Services,
University of Alaska Anchorage, Anchorage, AK</aff><aff id="A3"><label>4</label>Planned Parenthood Great Northwest, Hawai&#x02019;i, Alaska,
Indiana, Kentucky, Seattle, WA</aff><aff id="A4"><label>5</label>Planned Parenthood of Southern New England, New Haven,
CT</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1"><bold><italic toggle="yes">Authors&#x02019; contributions.</italic></bold> BGM
prepared the manuscript and completed the final edits; BGM, BLH, JV, DKK
contributed to writing and designing the methodology; BLH, JV, IP, JJ
performed data extraction and interpretation; BLH, JV conducted the
statistical analyses. All authors contributed to the conceptualization,
review and editing of the manuscript; all authors read and approved the
final manuscript.</p></fn><corresp id="CR1"><bold>Corresponding Author:</bold> Bonnie G McRee, PhD, MPH,
Assistant Professor, Department of Public Health Sciences, University of
Connecticut, School of Medicine, Farmington, CT 06030-6325,
<email>mcree@uchc.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>14</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>03</day><month>8</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>4</month><year>2025</year></pub-date><volume>46</volume><issue>2</issue><fpage>452</fpage><lpage>460</lpage><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P2">The increasing prevalence of fetal alcohol spectrum disorders is a
critical public health issue. Two behaviors, consuming alcohol and using
less effective pregnancy prevention, may result in alcohol-exposed
pregnancies (AEPs) in individuals who can become pregnant. In the context of
alcohol Screening and Brief Intervention (SBI) services, cutoff scores on
widely used alcohol risk assessments (e.g., Alcohol Use Disorders
Identification Test [USAUDIT]), may fail to identify individuals whose
relatively low alcohol consumption may still put them at risk for an AEP due
to their pregnancy prevention method.</p></sec><sec id="S2"><title>Methods</title><p id="P3">To identify this gap in alcohol SBI service delivery, we examined
data from two reproductive healthcare systems implementing alcohol SBI, to
explore the prevalence of individuals who met both of the following risk
conditions: reported any alcohol use on the USAUDIT and a pregnancy
prevention method &#x0003c;88% effective. Electronic health records for
individuals ages 18&#x02013;49 presenting for preventive care in 2021 were
analyzed.</p></sec><sec id="S3"><title>Results:</title><p id="P4">Of 11567 screened, 7638 reported some alcohol use, but screened at a
lower-risk level and were not flagged to receive an alcohol-focused BI. Of
these, 1477 were using a method of pregnancy prevention that was less than
88% effective. Additionally, 118 of the 1676 who screened positive on the
USAUDIT were using less effective contraception and did not receive a BI. In
summary, the number of individuals at risk of an AEP who did not receive an
alcohol BI was 1595 (13.8%) of the total patients screened for at-risk
alcohol use.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P5">There is a need for systems modifications to assess multiple
behaviors simultaneously and alert providers when a combination of behaviors
increases a specific health risk, such as an AEP. Tailored alcohol BIs that
include the risks/benefits of various pregnancy prevention methods to reduce
AEPs provide opportunities to enhance the reach of standard alcohol SBI
services.</p></sec></abstract><kwd-group><kwd>Alcohol Screening and Brief Intervention</kwd><kwd>Screening</kwd><kwd>Brief Intervention and Referral to Treatment</kwd><kwd>Alcohol Use Disorders Identification Test</kwd><kwd>Alcohol-Exposed Pregnancy</kwd><kwd>Fetal Alcohol Spectrum Disorders</kwd><kwd>Contraception Effectiveness</kwd><kwd>Pregnancy Prevention</kwd><kwd>USAUDIT</kwd><kwd>SBI</kwd><kwd>SBIRT</kwd><kwd>FASD</kwd></kwd-group></article-meta></front><body><sec id="S5"><title>INTRODUCTION</title><p id="P6">Prenatal alcohol exposure is a leading preventable cause of birth defects and
neurodevelopmental disorders in the United States (US). Fetal alcohol spectrum
disorders (FASD) is a term used to describe a range of behavioral, intellectual, and
physical problems that may appear at any time during childhood and last a
lifetime.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> Due to the high
rates of alcohol use and unintended pregnancies common in the US, the preconception
period provides a clinical opportunity to educate individuals who may become
pregnant to reduce the risk of alcohol-exposed pregnancies (AEPs).<sup><xref rid="R2" ref-type="bibr">2</xref></sup> Evidence suggests that early
intervention approaches, such as alcohol screening and brief intervention (SBI),
have the potential to reduce the harm from alcohol on maternal and infant
health.<sup><xref rid="R3" ref-type="bibr">3</xref></sup></p><p id="P7">According to its Chronic Disease Indicators, the Centers for Disease Control
and Prevention (CDC) estimates that approximately 45% of all pregnancies in the US
are unintended.<sup><xref rid="R4" ref-type="bibr">4</xref></sup> An unintended
pregnancy is defined as one that is either unwanted, that is, the pregnancy occurred
when no children or no more children were desired; or the pregnancy was mistimed.
Most unintended pregnancies result from not using contraception or from not using it
consistently or correctly.<sup><xref rid="R4" ref-type="bibr">4</xref></sup>
Further, data from CDC&#x02019;s Behavioral Risk Factor Surveillance System indicate
that approximately half of adult women in the US report drinking alcohol in the past
30 days and 18% of those 18&#x02013;44 years of age binge drink, consuming four or
more drinks per occasion.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> During
2018&#x02013;2020, 13.5% of pregnant adults reported current drinking, while 5.2%
reported binge drinking.<sup><xref rid="R6" ref-type="bibr">6</xref></sup></p><p id="P8">Alcohol SBI is an evidence-based clinical preventive service to identify and
treat patients who are drinking at levels that put them at risk for short-term or
long-term harms.<sup><xref rid="R7" ref-type="bibr">7</xref>&#x02013;<xref rid="R10" ref-type="bibr">10</xref></sup> Alcohol SBI involves the use of 1) validated
screening tools to classify patients&#x02019; risk levels, followed by 2) a short
conversation with patients who are drinking too much and are at &#x02018;moderate- or
high-risk&#x02019; for harm. These BIs are designed to motivate patients to reduce
their drinking levels or to accept a referral to specialty care as needed.<sup><xref rid="R9" ref-type="bibr">9</xref></sup> A primary goal of this current
initiative was to educate individuals at risk of an AEP through the implementation
of alcohol SBI services in healthcare systems.</p><p id="P9">Although a number of reliable and valid alcohol screening tools exist, the
World Health Organization&#x02019;s (WHO&#x02019;s) Alcohol Use Disorders
Identification Test or AUDIT has been the most widely tested for screening in
primary health care settings.<sup><xref rid="R11" ref-type="bibr">11</xref>&#x02013;<xref rid="R14" ref-type="bibr">14</xref></sup> The AUDIT
screens for the full spectrum of alcohol misuse and provides an assessment of
lower-, moderate- or high-risk use. Based on the AUDIT-linked alcohol SBI protocol,
patients who screen at moderate- or high-risk levels should receive a BI while those
who screen at lower-risk levels do not.<sup><xref rid="R11" ref-type="bibr">11</xref></sup> Methods for identifying an individual&#x02019;s risk status,
based solely on a positive AUDIT (or other screen) score, will fail to identify
patients drinking at low levels and who may be using less effective contraception.
Consequently, the provider may miss an opportunity for an AEP prevention-focused
educational intervention.<sup><xref rid="R15" ref-type="bibr">15</xref></sup></p><p id="P10">Over 30 years of implementation and effectiveness research has shown that
BIs, when implemented and delivered with fidelity, can reduce the amount of alcohol
consumed and associated problems in those who are drinking too much<sup><xref rid="R7" ref-type="bibr">7</xref>&#x02013;<xref rid="R9" ref-type="bibr">9</xref></sup>; however, a focus on early intervention for multiple
behavioral risk factors should be addressed to improve the quality of health
care.<sup><xref rid="R16" ref-type="bibr">16</xref>&#x02013;<xref rid="R19" ref-type="bibr">19</xref></sup> There have been fewer trials regarding
implementation and effectiveness of interventions to reduce the risk of AEPs in
individuals who may become pregnant. In a recent systematic review, Reid et al.
described the results of 19 studies to evaluate preconception interventions to
change alcohol use and/or contraceptive behavior, many of which were based on the
seminal work of Floyd and colleagues.<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R20" ref-type="bibr">20</xref></sup> Although the
interventions reviewed were more intensive than a typical BI session, 4 face-to-face
single-session interventions were effective in reducing the potential for
AEPs.<sup><xref rid="R21" ref-type="bibr">21</xref>&#x02013;<xref rid="R24" ref-type="bibr">24</xref></sup> Results of the overall systematic review
indicated that many of the 19 interventions reduced AEP risk during the
preconception period by preventing unplanned pregnancy and that changes in AEP risk
were driven primarily by changes in contraception behavior; although, some
approaches documented changes in both alcohol and contraception behavior.<sup><xref rid="R2" ref-type="bibr">2</xref></sup></p><p id="P11">The background for this investigation was a cooperative agreement, funded by
the Centers for Disease Control and Prevention across healthcare systems and
academic institutions, to implement alcohol screening and brief intervention
services.<sup><xref rid="R25" ref-type="bibr">25</xref></sup> The aim of
this cross-sectional study was to identify the potential gap in alcohol SBI service
delivery, by examining administrative data from two large reproductive health care
systems: Planned Parenthood of Southern New England (PPSNE) and Planned Parenthood
Great Northwest, Hawai&#x02019;i, Alaska, Indiana, Kentucky (PPGNHAIK) to explore the
prevalence of individuals who reported alcohol use that was categorized as
&#x02018;lower-risk&#x02019; on the USAUDIT screening tool, were using a &#x0201c;less
effective&#x0201d; method of pregnancy prevention, and did not receive an
alcohol-focused BI.</p><p id="P12">In the context of traditional alcohol SBI services, these patients would not
be flagged to receive a BI because they did not meet the threshold for moderate- or
high-risk use; however, they may be at risk of an AEP due to their method of
pregnancy prevention. Opportunities for integrating electronic health record (EHR)
flags to consider pregnancy prevention methods in conjunction with lower-risk
drinking cutoff scores on standardized screening tools are discussed. Opportunities
for providing AEP prevention-focused BIs are also considered.</p></sec><sec id="S6"><title>METHODS</title><sec id="S7"><title>Sample Selection.</title><p id="P13">Ethics approval for the study was conducted in compliance with each
academic institution&#x02019;s review board: University of Connecticut School of
Medicine (exempt) and University of Alaska Anchorage (expedited). The combined
study sample is comprised of data from the two health system affiliates, PPSNE
and PPGNHAIK. PPSNE data are from 15 health centers in Connecticut and Rhode
Island, while PPGNHAIK data are from 18 health centers across Washington state.
The sample for both health systems comprises females (sex assigned at birth),
18&#x02013;49 years of age who received preventive care between 1/1/2021 and
12/31/2021. Patients who were not screened for alcohol use or who did not have a
recorded method of pregnancy prevention were excluded from the analyses. For
patients who were seen for more than one preventive care visit during the year,
the first visit with complete study data was utilized. For the combined sample,
the initial data set included 13994 preventive visits of which 13521 were unique
visits. After excluding incomplete data, the final sample was 11567. Due to the
geographic locations of the health systems, differences in patient demographics
and substance use were expected; however, the intent of this study was not to
compare the two systems, but to highlight the screening and BI results of two
healthcare systems implementing alcohol SBI services in a similar manner.</p></sec><sec id="S8"><title>Measures.</title><p id="P14">Administrative data from each system&#x02019;s EHR included 1) substance
use information about alcohol and other drug use; 2) documentation of Brief
Intervention (BI) completion; and 3) method of pregnancy prevention as reported
during the visit. Patient demographic data of sex, age, race/ethnicity and
insurance coverage were also included.</p><p id="P15">EHR documentation accuracy was maintained through a variety of
mechanisms including EHR data audits, feedback loops with health center
managers, on-site clinician monitoring visits and technical assistance calls
with health center staff.</p><sec id="S9"><title>Alcohol Risk Score.</title><p id="P16">Validated screening instruments were incorporated into each health
system&#x02019;s EHR to collect alcohol and other drug use information.
Quality improvement protocols ensured the completion and accuracy of the
screening assessments. These included screening rate monitoring,
health-center specific reporting and routine technical assistance that
included role-play activities.</p><p id="P17">The Alcohol Use Disorders Identification Test or AUDIT, developed by
the WHO, is a widely used alcohol screening tool designed to measure risk
related to alcohol use in general health care settings.<sup><xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R13" ref-type="bibr">13</xref></sup> The U.S. version of the AUDIT, the USAUDIT,<sup><xref rid="R12" ref-type="bibr">12</xref></sup> was used by the two health
systems reported in this study. It consists of 10 questions that ask about
alcohol use in the past year, with the first three questions serving as a
pre-screen assessment. Points for each question range from 0&#x02013;6 for
the first three questions and 0&#x02013;4 for the remaining seven questions.
Scores for all 10 questions are summed to compute a total Alcohol Risk Score
ranging from 0&#x02013;46. A higher score indicates greater risk.</p><p id="P18">The risk range cutoffs for females were utilized for the study. A
Risk Score of 0 indicates that the patient is currently abstinent. Alcohol
Risk Scores of 1&#x02013;6 indicate &#x02018;lower-risk,&#x02019; where a
patient may be drinking, but likely within the recommended guidelines for
healthy individuals. No further action is typically required for individuals
at &#x02018;lower-risk.&#x02019; Risk Scores of 7&#x02013;24 indicate
&#x02018;moderate-risk,&#x02019; indicating a patient may be drinking above
the recommended guidelines and/or experiencing some problems related to
alcohol use. A BI for these individuals would be conducted to motivate the
patient to modify their drinking pattern to be within the recommended
guidelines to reduce associated risks. Scores greater than 25 indicate that
the patient may be experiencing harms related to drinking and a referral for
further assessment would be warranted. For patients who are pregnant, a
score of 1 or more would warrant a brief intervention to discuss health
risks, including FASDs.</p><p id="P19">The total USAUDIT screening score is recorded in the EHR for each
patient. As indicated above, a score of 1&#x02013;6 for healthy individuals
typically indicates &#x02018;lower-risk,&#x02019; and no further intervention
would be needed. However, for this study, we examined those who scored in
this &#x02018;lower-risk&#x02019; range in conjunction with their potential
for pregnancy as defined by the effectiveness of their current method of
pregnancy prevention to determine if a BI would have been appropriate.</p></sec><sec id="S10"><title>Assessment of Other Drug Use.</title><p id="P20">A common component of an SBIRT program includes the assessment of
other drug use with validated screening instruments.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> PPSNE utilized the Alcohol, Smoking
and Substance Involvement Screening Test, Frequency and Concern Items
(ASSIST-FC)<sup><xref rid="R26" ref-type="bibr">26</xref></sup>;
while PPGNHAIK screened patients using the 10-item Drug Abuse Screening Test
(DAST-10).<sup><xref rid="R27" ref-type="bibr">27</xref></sup> For
patients who reported any drug use, clinic staff recorded in the EHR which
drug(s) were used.</p></sec><sec id="S11"><title>Method of Pregnancy Prevention.</title><p id="P21">The patient&#x02019;s method of pregnancy prevention was recorded by
the clinician and used to determine whether the patient was at risk for
pregnancy. Method of pregnancy prevention is classified in terms of
effectiveness.<sup><xref rid="R28" ref-type="bibr">28</xref></sup></p><p id="P22"><xref rid="T1" ref-type="table">Table 1</xref> describes the methods
identified as &#x0201c;more effective&#x0201d; in preventing pregnancy (e.g.,
implant, intrauterine device) compared to those that are &#x0201c;less
effective&#x0201d; (e.g., condoms, spermicide). More effective methods of
pregnancy prevention include contraception options that are approximately
88% effective or greater in preventing pregnancy, and often referred to as
Tier 1 or Tier 2 contraception methods.<sup><xref rid="R28" ref-type="bibr">28</xref></sup> Additionally, documentation of menopause,
abstinence, and same-sex partner were classified as more effective.
Pregnancy prevention methods classified as less effective are less than 88%
effective and typically referred to as Tier 3.</p></sec><sec id="S12"><title>Brief Intervention Documentation.</title><p id="P23">EHR documentation of clinician-patient discussion components was
used to identify whether an alcohol BI was completed. At PPSNE, clinicians
identify the content of the BI within the EHR by selecting available BI
&#x0201c;smart-phrases&#x0201d; such as &#x0201c;discussed the risks related to
alcohol use,&#x0201d; or &#x0201c;advised the patient to cut down on alcohol
use.&#x0201d; At PPGNHAIK, BIs are documented in the EHR via a series of
checkboxes that providers use to indicate if they discussed or advised
patients regarding their alcohol use. Examples included &#x0201c;advised of
health risks,&#x0201d; and &#x0201c;discussed patient reasons/ability for
change.&#x0201d;</p><p id="P24">BI fidelity was guided by the EHR modifications that included the
addition of BI order-sets and incorporation of smart-phrases to guide the
interventions. EHR rate audits of completed BIs, online and in-person
technical assistance, and incorporation of alcohol SBI modules into new-hire
training and certification were used to monitor and improve clinician
delivery of BI services.</p></sec></sec><sec id="S13"><title>Participants.</title><p id="P25">Participant characteristics are described in <xref rid="T2" ref-type="table">Table 2</xref> for each healthcare system and for the
combined sample. As expected, there were differences across the two healthcare
systems with regard to socio-demographic and substance use characteristics. The
combined sample included 11567 patients, 61.9% of whom identified as White,
14.2% as Black, and 8.0% as Asian/Pacific Islander; although, a higher
percentage of Black patients are seen in PPSNE (20.8% vs. 7.7%) while a higher
proportion of Asian/Pacific Islander patients are observed in PPGNHAIK (13.1% vs
2.8%) due to the geographic location of the health centers. In PPSNE, 25.0% of
patients were of Hispanic ethnicity; however, with the exception of White race,
Hispanic ethnicity was not reported separately from race at PPGNHAIK. On
average, the female patients were 30 years old and approximately half received
publicly supported health insurance or were uninsured. The predominant other
drug used by patients at both health systems was marijuana.</p><p id="P26">Between the two health systems, patient substance use behavior and
pregnancy prevention methods also differed. Overall, 66.1% of the combined
sample of patients reported current lower-risk alcohol (64.1% percent of PPSNE
and 68.0% of PPGNHAIK patients), and 23.8% of the combined sample used less
effective contraception at the time of their visit (29.8% of PPSNE and 18.0% of
PPGNHAIK patients). Overall, 14.4% of patients scored in the moderate- or
high-risk alcohol use range on the USAUDIT (18.2% of PPSNE patients and 10.9% of
PPGNHAIK patients).</p></sec><sec id="S14"><title>Data Analysis.</title><p id="P27">Frequency statistics and chi-square analyses were conducted using IBM
SPSS Statistics version 28.</p></sec></sec><sec id="S15"><title>RESULTS</title><p id="P28">Despite the significant differences in sample characteristics across the two
health systems, between sample outcomes related to SBI delivery did not vary
significantly, and for this reason the sample data were combined for the analyses.
<xref rid="F1" ref-type="fig">Figure 1</xref> shows the combined samples of the
11567 screened patients. Of those, 7638 (66%) reported some alcohol use, but
screened at a lower-risk level and thus would not have been flagged to receive an
alcohol-focused BI based on their USAUDIT Risk Score. Of those reporting lower-risk
use, 6439 (84.3%) did not receive a BI, consistent with the standard alcohol SBI
protocol since they did not screen positive for at-risk alcohol use. Of those who
were lower-risk drinkers and did not receive a BI, 1477 (22.9%) were using less
effective pregnancy prevention and were therefore at risk of an AEP. Among the
lower-risk alcohol group, there were no significant differences in receiving a BI
based on effectiveness of pregnancy prevention for PPSNE
(&#x003c7;<sup>2</sup><sub>(1, 3653)</sub>=3.45, <italic toggle="yes">p</italic>=.06) or
PPGNHAIK (&#x003c7;<sup>2</sup><sub>(1, 3985)</sub>=1.31, <italic toggle="yes">p</italic>=.25),
indicating providers were equally likely to provide a BI to patients using effective
pregnancy prevention as those patients using less effective pregnancy
prevention.</p><p id="P29">Of the total screened sample, 1676 (14.5%) would have been flagged for a BI
based on their Alcohol Risk Score (<xref rid="F1" ref-type="fig">Figure 1</xref>).
The majority of patients screening positive and flagged for at-risk alcohol use
(moderate- or high-risk) received a BI, 1162 (69.3%) while 514 (30.7%) did not
receive a BI. Of those missed, 118 (23.0%) were using less effective pregnancy
prevention and were therefore at risk of an AEP. Like the lower-risk alcohol group,
in this at-risk alcohol use group, there were no significant differences in
receiving a BI based on effectiveness of pregnancy prevention for PPSNE
(&#x003c7;<sup>2</sup><sub>(1, 1038)</sub>=2.42, <italic toggle="yes">p</italic>=.12) or
PPGNHAIK (&#x003c7;<sup>2</sup><sub>(1, 638)</sub>=2.64, <italic toggle="yes">p</italic>=.10).
While the likelihood of receiving a BI did not differ based on pregnancy prevention
method, overall, BIs were delivered more often to patients who screened positive for
at-risk alcohol use than those reporting lower-risk alcohol use. In summary, the
number of individuals at risk of an AEP who did not receive an alcohol BI were 1595
(13.8%) of the total number of patients screened for at-risk alcohol use.</p></sec><sec id="S16"><title>Discussion.</title><p id="P30">The primary focus of this study was to identify the potential gap in alcohol
SBI service delivery by examining the prevalence of individuals who reported alcohol
use that was categorized as &#x02018;lower-risk&#x02019; on the USAUDIT screening
tool, were using a less effective method of pregnancy prevention, and did not
receive an alcohol-focused BI. Full integration of a preventive practice that
included universal administration of a valid, standardized screening tool, automated
scoring and EHR-based provider alerts when patients screened positive, still missed
an opportunity to provide an alcohol-related intervention to approximately 14% of
individuals who reported consuming some alcohol and reported using a less reliable
form of pregnancy prevention, a combination of behaviors that increased their risk
for an AEP.</p><p id="P31">The continued focus in health care on screening and intervening on singular
behavioral risk factors has been reported as a substantial area for improving the
quality of care.<sup><xref rid="R16" ref-type="bibr">16</xref>&#x02013;<xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R29" ref-type="bibr">29</xref></sup> Like many health conditions that involve integrating
behavioral and medical care,<sup><xref rid="R30" ref-type="bibr">30</xref></sup>
preventing FASDs involves addressing not only alcohol use, but also identifying and
addressing concurrent behaviors that contribute to pregnancy such as contraception
use.<sup><xref rid="R31" ref-type="bibr">31</xref></sup> This finding
underscores the insufficiency of intervening on alcohol risk alone, without
considering additional risk factors for AEP, and a need for interventions, tools and
systems that are sufficiently flexible to assess multiple behaviors
simultaneously.<sup><xref rid="R16" ref-type="bibr">16</xref></sup></p><p id="P32">An EHR approach that uses patient-specific data to prioritize and tailor
interventions is recommended given the potential of EHRs to not only document
relevant demographic, physiological, health risk, and behavioral data, but to also
combine data to guide care.<sup><xref rid="R32" ref-type="bibr">32</xref>&#x02013;<xref rid="R35" ref-type="bibr">35</xref></sup> While some
progress has been made in using the medical information in the EHR to optimize
medication prescribing for patients with chronic conditions (e.g., diabetes,
cancer), the EHR&#x02019;s usefulness in combining information to guide brief
interventions is an unexplored opportunity.</p><sec id="S17"><title>Limitations.</title><p id="P33">The generalizability of these findings and recommendations are limited
by the study of sexual and reproductive health care systems delivered across two
regional affiliates. These systems used different EHRs and served
demographically different patient populations, and their system of care differs
from other primary care services. One could expect other systems implementing
alcohol SBI that are less specialized in women&#x02019;s health and reproductive
care may miss even more patients at risk for AEP because contraception use may
not be a visit priority. Attending to bias in service delivery is recommended to
reduce stigmatizing subgroups of patients or inequalities in services
received.<sup><xref rid="R36" ref-type="bibr">36</xref>&#x02013;<xref rid="R38" ref-type="bibr">38</xref></sup></p></sec><sec id="S18"><title>Conclusions.</title><p id="P34">The goal of this federally funded initiative was to implement alcohol
SBI for patients who may be at heightened risk for an AEP, with the ultimate
goal of preventing FASDs. This required modification to traditional SBI services
to include education and training materials, as well as modification to EHR
systems. This study explores the gap in the provision of alcohol SBI services
for patients who use less effective pregnancy prevention, especially those who
drink at lower-risk levels and therefore would not have been identified as
needing a BI. Integrating EHR flags to take into account pregnancy prevention
methods with lower-risk drinking cutoff scores would provide opportunities for
AEP prevention-focused BIs. Universal, systemized approaches that assist
providers in identifying patients with multiple risk factors related to an AEP
will ensure that patients are educated regarding information and advice to
optimize health outcomes.</p></sec></sec></body><back><ack id="S19"><title>Acknowledgements.</title><p id="P35">The authors wish to acknowledge our partners and collaborators at Planned
Parenthood Great Northwest, Hawai&#x000ec;, Alaska, Indiana, Kentucky; and Planned
Parenthood of Southern New England.</p><sec id="S20"><title>Funding.</title><p id="P36">All sites and authors were supported by cooperative agreements from the
Centers for Disease Control and Prevention awarded under
CDC-RFA-DD18&#x02013;1802: [grant numbers NU84DD000004 (UConn Health),
NU84DD000005 (University of Alaska, Anchorage)]. The supporting organization had
no further role in the design; in the collection, analysis, and interpretation
of the data; or in writing the manuscript.</p></sec></ack><fn-group><fn fn-type="COI-statement" id="FN2"><p id="P37"><bold><italic toggle="yes">Conflict of Interest Statement</italic></bold>: The
authors declare no conflicting interests.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="R1"><label>1.</label><mixed-citation publication-type="webpage"><source>NIAAA spectrum, volume 12, issue 3, fall</source>
<year>2020</year>.
<comment>chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/<ext-link xlink:href="https://www.spectrum.niaaa.nih.gov/Content/archives/Fall_2020.pdf" ext-link-type="uri">https://www.spectrum.niaaa.nih.gov/Content/archives/Fall_2020.pdf</ext-link></comment>.</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Reid</surname><given-names>N</given-names></name>, <name><surname>Sch&#x000f6;lin</surname><given-names>L</given-names></name>, <name><surname>Erng</surname><given-names>MN</given-names></name>, <name><surname>Montag</surname><given-names>A</given-names></name>, <name><surname>Hanson</surname><given-names>J</given-names></name>, <name><surname>Smith</surname><given-names>L</given-names></name>. <article-title>Preconception interventions to reduce the risk of
alcohol-exposed pregnancies: A systematic review</article-title>.
<source>Alcohol Clin Exp Res</source>.
<year>2021</year>;<volume>45</volume>(<issue>12</issue>):<fpage>2414</fpage>&#x02013;<lpage>2429</lpage>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1111/acer.14725</pub-id>.<pub-id pub-id-type="pmid">34590331</pub-id>
</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="book"><name><surname>Sch&#x000f6;lin</surname><given-names>L</given-names></name>
<source>Prevention of harm caused by alcohol exposure in pregnancy: Rapid review and case studies from member states</source>. <publisher-name>World Health
Organization. Regional Office for Europe</publisher-name>;
<year>2016</year>.</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><collab>Centers for Disease Control and
Prevention</collab>. <source>Reproductive health</source>
<comment><ext-link xlink:href="https://www.cdc.gov/reproductivehealth/contraception/unintendedpregnancy/index.htm" ext-link-type="uri">https://www.cdc.gov/reproductivehealth/contraception/unintendedpregnancy/index.htm</ext-link></comment>.
<comment>Updated</comment>
<year>2023</year>. <date-in-citation>Accessed May 25,
2022.</date-in-citation></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><collab>Centers for Disease Control and
Prevention</collab>. <source>Alcohol and public health</source>.
<comment><ext-link xlink:href="https://www.cdc.gov/alcohol/fact-sheets/womens-health.htm" ext-link-type="uri">https://www.cdc.gov/alcohol/fact-sheets/womens-health.htm</ext-link></comment>.
<comment>Updated</comment>
<year>2022</year>. <date-in-citation>Accessed May 25,
2022.</date-in-citation></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Gosdin</surname><given-names>LK</given-names></name>. <article-title>Alcohol consumption and binge drinking during pregnancy
among adults aged 18&#x02013;49 years &#x02014; united states,
2018&#x02013;2020</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2022</year>;<volume>71</volume>. <comment><ext-link xlink:href="https://www.cdc.gov/mmwr/volumes/71/wr/mm7101a2.htm" ext-link-type="uri">https://www.cdc.gov/mmwr/volumes/71/wr/mm7101a2.htm</ext-link></comment>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.15585/mmwr.mm7101a2</pub-id>.</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Babor</surname><given-names>TF</given-names></name>, <name><surname>McRee</surname><given-names>BG</given-names></name>, <name><surname>Kassebaum</surname><given-names>PA</given-names></name>, <name><surname>Grimaldi</surname><given-names>PL</given-names></name>, <name><surname>Ahmed</surname><given-names>K</given-names></name>, <name><surname>Bray</surname><given-names>J</given-names></name>. <article-title>Screening, brief intervention, and referral to treatment
(SBIRT): Toward a public health approach to the management of substance
abuse</article-title>. <source>Subst Abus</source>.
<year>2007</year>;<volume>28</volume>(<issue>3</issue>):<fpage>7</fpage>&#x02013;<lpage>30</lpage>.
<date-in-citation>Accessed Jan 11, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1300/J465v28n03_03</pub-id>.<pub-id pub-id-type="pmid">18077300</pub-id>
</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Bray</surname><given-names>JW</given-names></name>, <name><surname>Del Boca</surname><given-names>FK</given-names></name>, <name><surname>McRee</surname><given-names>BG</given-names></name>, <name><surname>Hayashi</surname><given-names>SW</given-names></name>, <name><surname>Babor</surname><given-names>TF</given-names></name>. <article-title>Screening, brief intervention and referral to treatment
(SBIRT): Rationale, program overview and cross-site
evaluation</article-title>. <source>Addiction</source>.
<year>2017</year>;<volume>112</volume>
<issue>Suppl 2</issue>:<fpage>3</fpage>&#x02013;<lpage>11</lpage>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1111/add.13676</pub-id>.</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><collab>Centers for Disease
Control</collab>. <source>Planning and implementing screening and brief intervention for risky alcohol use: A step-by-step guide for primary care practices</source>.. <year>2014</year>.</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Moyer</surname><given-names>VA</given-names></name>. <article-title>Screening and behavioral counseling interventions in
primary care to reduce alcohol misuse: U.S. preventive services task force
recommendation statement</article-title>. <source>Ann Intern Med</source>.
<year>2013</year>;<volume>159</volume>(<issue>3</issue>):<fpage>210</fpage>&#x02013;<lpage>218</lpage>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.7326/0003-4819-159-3-201308060-00652</pub-id>.<pub-id pub-id-type="pmid">23698791</pub-id>
</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Babor</surname><given-names>TF</given-names></name>, <name><surname>Higgins-Biddle</surname><given-names>JC</given-names></name>, <name><surname>Saunders</surname><given-names>JB</given-names></name>, <name><surname>Monteiro</surname><given-names>MG</given-names></name>. <source>AUDIT the alcohol use disorders identification test: Guidelines for use in primary care, second edition</source>..
<year>2001</year>.</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Babor</surname><given-names>TF</given-names></name>, <name><surname>Higgins-Biddle</surname><given-names>JC</given-names></name>, <name><surname>Robaina</surname><given-names>K</given-names></name>. <source>USAUDIT the alcohol use disorders identification test, adapted for use in the united states: A guide for primary care practitioners</source>.. <year>2018</year>.</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Saunders</surname><given-names>JB</given-names></name>, <name><surname>Aasland</surname><given-names>OG</given-names></name>, <name><surname>Babor</surname><given-names>TF</given-names></name>, <name><surname>de la Fuente</surname><given-names>JR</given-names></name>, <name><surname>Grant</surname><given-names>M</given-names></name>. <article-title>Development of the alcohol use disorders identification
test (AUDIT): WHO collaborative project on early detection of persons with
harmful alcohol consumption--II</article-title>. <source>Addiction</source>.
<year>1993</year>;<volume>88</volume>(<issue>6</issue>):<fpage>791</fpage>&#x02013;<lpage>804</lpage>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1111/j.1360-0443.1993.tb02093.x</pub-id>.<pub-id pub-id-type="pmid">8329970</pub-id>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Higgins-Biddle</surname><given-names>JC</given-names></name>, <name><surname>Babor</surname><given-names>TF</given-names></name>. <article-title>A review of the alcohol use disorders identification
test (AUDIT), AUDIT-C, and USAUDIT for screening in the united states: Past
issues and future directions</article-title>. <source>Am J Drug Alcohol Abuse</source>.
<year>2018</year>;<volume>44</volume>(<issue>6</issue>):<fpage>578</fpage>&#x02013;<lpage>586</lpage>.
<comment><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217805/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217805/</ext-link></comment>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1080/00952990.2018.1456545</pub-id>.<pub-id pub-id-type="pmid">29723083</pub-id>
</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Poole</surname><given-names>N</given-names></name>, <name><surname>Schmidt</surname><given-names>RA</given-names></name>, <name><surname>Bocking</surname><given-names>A</given-names></name>, <name><surname>Bergeron</surname><given-names>J</given-names></name>, <name><surname>Fortier</surname><given-names>I</given-names></name>. <article-title>The potential for fetal alcohol spectrum disorder
prevention of a harmonized approach to data collection about alcohol use in
pregnancy cohort studies</article-title>. <source>Int J Environ Res Public Health</source>.
<year>2019</year>;<volume>16</volume>(<issue>11</issue>):<fpage>2019</fpage>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.3390/ijerph16112019</pub-id>.<pub-id pub-id-type="pmid">31174290</pub-id>
</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Babor</surname><given-names>TF</given-names></name>, <name><surname>Sciamanna</surname><given-names>CN</given-names></name>, <name><surname>Pronk</surname><given-names>NP</given-names></name>. <article-title>Assessing multiple risk behaviors in primary care.
screening issues and related concepts</article-title>. <source>Am J Prev Med</source>. <year>2004</year>;<volume>27</volume>(<issue>2
Suppl</issue>):<fpage>42</fpage>&#x02013;<lpage>53</lpage>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1016/j.amepre.2004.04.018</pub-id>.</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Eder</surname><given-names>M</given-names></name>, <name><surname>Henninger</surname><given-names>M</given-names></name>, <name><surname>Durbin</surname><given-names>S</given-names></name>, <etal/>
<article-title>Screening and interventions for social risk factors: Technical
brief to support the US preventive services task force</article-title>.
<source>JAMA</source>.
<year>2021</year>;<volume>326</volume>(<issue>14</issue>):<fpage>1416</fpage>&#x02013;<lpage>1428</lpage>.
<date-in-citation>Accessed 1/16/2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1001/jama.2021.12825</pub-id>.<pub-id pub-id-type="pmid">34468710</pub-id>
</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Guertler</surname><given-names>D</given-names></name>, <name><surname>Moehring</surname><given-names>A</given-names></name>, <name><surname>Krause</surname><given-names>K</given-names></name>, <etal/>
<article-title>Proactive multipurpose health risk screening in health care
settings: Methods, design, and reach</article-title>. <source>Int J Methods Psychiatr Res</source>.
<year>2019</year>;<volume>28</volume>(<issue>1</issue>):<fpage>e1760</fpage>.
<comment><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877248/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877248/</ext-link></comment>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1002/mpr.1760</pub-id>.<pub-id pub-id-type="pmid">30614134</pub-id>
</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Rose</surname><given-names>GL</given-names></name>, <name><surname>Ferraro</surname><given-names>TA</given-names></name>, <name><surname>Skelly</surname><given-names>JM</given-names></name>, <etal/>
<article-title>Feasibility of automated pre-screening for lifestyle and
behavioral health risk factors in primary care</article-title>. <source>BMC Fam Pract</source>.
<year>2015</year>;<volume>16</volume>:<fpage>150</fpage>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1186/s12875-015-0368-9</pub-id>.<pub-id pub-id-type="pmid">26497902</pub-id>
</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Floyd</surname><given-names>RL</given-names></name>, <name><surname>Sobell</surname><given-names>M</given-names></name>, <name><surname>Velasquez</surname><given-names>MM</given-names></name>, <etal/>
<article-title>Preventing alcohol-exposed pregnancies: A randomized controlled
trial</article-title>. <source>Am J Prev Med</source>.
<year>2007</year>;<volume>32</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>10</lpage>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1016/j.amepre.2006.08.028</pub-id>.<pub-id pub-id-type="pmid">17218187</pub-id>
</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Ceperich</surname><given-names>SD</given-names></name>, <name><surname>Ingersoll</surname><given-names>KS</given-names></name>. <article-title>Motivational interviewing + feedback intervention to
reduce alcohol-exposed pregnancy risk among college binge drinkers:
Determinants and patterns of response</article-title>. <source>J Behav Med</source>.
<year>2011</year>;<volume>34</volume>(<issue>5</issue>):<fpage>381</fpage>&#x02013;<lpage>395</lpage>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1007/s10865-010-9308-2</pub-id>.<pub-id pub-id-type="pmid">21318412</pub-id>
</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Ingersoll</surname><given-names>KS</given-names></name>, <name><surname>Ceperich</surname><given-names>SD</given-names></name>, <name><surname>Hettema</surname><given-names>JE</given-names></name>, <name><surname>Farrell-Carnahan</surname><given-names>L</given-names></name>, <name><surname>Penberthy</surname><given-names>JK</given-names></name>. <article-title>Preconceptional motivational interviewing interventions
to reduce alcohol-exposed pregnancy risk</article-title>. <source>J Subst Abuse Treat</source>.
<year>2013</year>;<volume>44</volume>(<issue>4</issue>):<fpage>407</fpage>&#x02013;<lpage>416</lpage>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1016/j.jsat.2012.10.001</pub-id>.<pub-id pub-id-type="pmid">23192220</pub-id>
</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Ingersoll</surname><given-names>KS</given-names></name>, <name><surname>Ceperich</surname><given-names>SD</given-names></name>, <name><surname>Nettleman</surname><given-names>MD</given-names></name>, <name><surname>Karanda</surname><given-names>K</given-names></name>, <name><surname>Brocksen</surname><given-names>S</given-names></name>, <name><surname>Johnson</surname><given-names>BA</given-names></name>. <article-title>Reducing alcohol-exposed pregnancy risk in college
women: Initial outcomes of a clinical trial of a motivational
intervention</article-title>. <source>J Subst Abuse Treat</source>.
<year>2005</year>;<volume>29</volume>(<issue>3</issue>):<fpage>173</fpage>&#x02013;<lpage>180</lpage>.
<comment><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875062/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875062/</ext-link></comment>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1016/j.jsat.2005.06.003</pub-id>.<pub-id pub-id-type="pmid">16183466</pub-id>
</mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Walker</surname><given-names>DS</given-names></name>, <name><surname>Fisher</surname><given-names>CSD</given-names></name>, <name><surname>Sherman</surname><given-names>A</given-names></name>, <name><surname>Wybrecht</surname><given-names>B</given-names></name>, <name><surname>Kyndely</surname><given-names>K</given-names></name>. <article-title>Fetal alcohol spectrum disorders prevention: An
exploratory study of women&#x02019;s use of, attitudes toward, and knowledge
about alcohol</article-title>. <source>J Am Acad Nurse Pract</source>.
<year>2005</year>;<volume>17</volume>(<issue>5</issue>):<fpage>187</fpage>&#x02013;<lpage>193</lpage>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1111/j.1745-7599.2005.0031.x</pub-id>.<pub-id pub-id-type="pmid">15854108</pub-id>
</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><collab>CDC-RFA-DD18&#x02013;1802</collab>.<source>pdf - implementing alcohol screening and brief intervention in healthcare systems providing women&#x02019;s health services</source>. <comment><ext-link xlink:href="https://govtribe.com/file/government-file/cdc-rfa-dd18-1802-dot-pdf-1" ext-link-type="uri">https://govtribe.com/file/government-file/cdc-rfa-dd18-1802-dot-pdf-1</ext-link></comment>.
<date-in-citation>Accessed Jan 11, 2024.</date-in-citation></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>McRee</surname><given-names>B</given-names></name>, <name><surname>Babor</surname><given-names>TF</given-names></name>, <name><surname>Lynch</surname><given-names>ML</given-names></name>, <name><surname>Vendetti</surname><given-names>JA</given-names></name>. <article-title>Reliability and validity of a two-question version of
the world health organization&#x02019;s alcohol, smoking and substance
involvement screening test: The ASSIST-FC</article-title>. <source>J Stud Alcohol Drugs</source>.
<year>2018</year>;<volume>79</volume>(<issue>4</issue>):<fpage>649</fpage>&#x02013;<lpage>657</lpage>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation><pub-id pub-id-type="pmid">30079882</pub-id>
</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Skinner</surname><given-names>HA</given-names></name>. <article-title>The drug abuse screening test</article-title>.
<source>Addict Behav</source>.
<year>1982</year>;<volume>7</volume>(<issue>4</issue>):<fpage>363</fpage>&#x02013;<lpage>371</lpage>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1016/0306-4603(82)90005-3</pub-id>.<pub-id pub-id-type="pmid">7183189</pub-id>
</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Trussell</surname><given-names>J</given-names></name>, <name><surname>Aiken</surname><given-names>A</given-names></name>, <name><surname>Micks</surname><given-names>E</given-names></name>, <name><surname>Guthrie</surname><given-names>KA</given-names></name>. <article-title>Efficacy, safety, and personal
considerations</article-title>. <source>Contraceptive technology</source>.
<year>2018</year>;<volume>21</volume>.</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Coups</surname><given-names>EJ</given-names></name>, <name><surname>Gaba</surname><given-names>A</given-names></name>, <name><surname>Orleans</surname><given-names>CT</given-names></name>. <article-title>Physician screening for multiple behavioral health risk
factors</article-title>. <source>Am J Prev Med</source>.
<year>2004</year>;<volume>27</volume>(<issue>2</issue>):<fpage>34</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">15275672</pub-id>
</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>L</given-names></name>, <name><surname>Payne</surname><given-names>EH</given-names></name>, <name><surname>Roseman</surname><given-names>K</given-names></name>, <etal/>
<article-title>Clinical workflow and substance use screening, brief
intervention, and referral to treatment data in the electronic health
records: A national drug abuse treatment clinical trials network
study</article-title>. <source>EGEMS (Wash DC)</source>.
<volume>7</volume>(<issue>1</issue>):<fpage>35</fpage>. <comment><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676918/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676918/</ext-link></comment>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.5334/egems.293</pub-id>.</mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Page</surname><given-names>K</given-names></name>, <name><surname>Murray-Krezan</surname><given-names>C</given-names></name>, <name><surname>Leeman</surname><given-names>L</given-names></name>, <name><surname>Carmody</surname><given-names>M</given-names></name>, <name><surname>Stephen</surname><given-names>JM</given-names></name>, <name><surname>Bakhireva</surname><given-names>LN</given-names></name>. <article-title>Prevalence of marijuana use in pregnant women with
concurrent opioid use disorder or alcohol use in pregnancy</article-title>.
<source>Addiction Science &#x00026; Clinical Practice</source>.
<year>2022</year>;<volume>17</volume>(<issue>1</issue>):<fpage>3</fpage>.
doi:
<pub-id pub-id-type="doi">10.1186/s13722-021-00285-z</pub-id>.<pub-id pub-id-type="pmid">34991713</pub-id>
</mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Oh</surname><given-names>S</given-names></name>, <name><surname>Lee</surname><given-names>SJ</given-names></name>, <name><surname>Noh</surname><given-names>J</given-names></name>, <name><surname>Mo</surname><given-names>J</given-names></name>. <article-title>Optimal treatment recommendations for diabetes patients
using the markov decision process along with the south korean electronic
health records</article-title>. <source>Sci Rep</source>.
<year>2021</year>;<volume>11</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>10</lpage>.
<comment><ext-link xlink:href="https://www.nature.com/articles/s41598-021-86419-4" ext-link-type="uri">https://www.nature.com/articles/s41598-021-86419-4</ext-link></comment>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1038/s41598-021-86419-4</pub-id>.<pub-id pub-id-type="pmid">33414495</pub-id>
</mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>Oh</surname><given-names>SH</given-names></name>, <name><surname>Lee</surname><given-names>SJ</given-names></name>, <name><surname>Park</surname><given-names>J</given-names></name>. <article-title>Precision medicine for hypertension patients with type 2
diabetes via reinforcement learning</article-title>. <source>J Pers Med</source>.
<year>2022</year>;<volume>12</volume>(<issue>1</issue>):<fpage>87</fpage>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.3390/jpm12010087</pub-id>.<pub-id pub-id-type="pmid">35055402</pub-id>
</mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Moja</surname><given-names>L</given-names></name>, <name><surname>Passardi</surname><given-names>A</given-names></name>, <name><surname>Capobussi</surname><given-names>M</given-names></name>, <etal/>
<article-title>Implementing an evidence-based computerized decision support
system linked to electronic health records to improve care for cancer
patients: The ONCO-CODES study protocol for a randomized controlled
trial</article-title>. <source>Implement Sci</source>.
<year>2016</year>;<volume>11</volume>:<fpage>153</fpage>. <comment><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123241/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123241/</ext-link></comment>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1186/s13012-016-0514-3</pub-id>.<pub-id pub-id-type="pmid">27884165</pub-id>
</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Roden</surname><given-names>DM</given-names></name>, <name><surname>Denny</surname><given-names>JC</given-names></name>. <article-title>Integrating electronic health record genotype and
phenotype datasets to transform patient care</article-title>. <source>Clin Pharmacol Ther</source>.
<year>2016</year>;<volume>99</volume>(<issue>3</issue>):<fpage>298</fpage>&#x02013;<lpage>305</lpage>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1002/cpt.321</pub-id>.<pub-id pub-id-type="pmid">26667791</pub-id>
</mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>Edwards</surname><given-names>A</given-names></name>, <name><surname>Kelsey</surname><given-names>B</given-names></name>, <name><surname>Pierce-Bulger</surname><given-names>M</given-names></name>, <etal/>
<article-title>Applying ethical principles when discussing alcohol use during
pregnancy</article-title>. <source>J Midwifery Womens Health</source>.
<year>2020</year>;<volume>65</volume>(<issue>6</issue>):<fpage>795</fpage>&#x02013;<lpage>801</lpage>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1111/jmwh.13159</pub-id>.<pub-id pub-id-type="pmid">32893962</pub-id>
</mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><name><surname>Higgins</surname><given-names>JA</given-names></name>, <name><surname>Carpenter</surname><given-names>E</given-names></name>, <name><surname>Everett</surname><given-names>BG</given-names></name>, <name><surname>Greene</surname><given-names>MZ</given-names></name>, <name><surname>Haider</surname><given-names>S</given-names></name>, <name><surname>Hendrick</surname><given-names>CE</given-names></name>. <article-title>Sexual minority women and contraceptive use: Complex
pathways between sexual orientation and health outcomes</article-title>.
<source>Am J Public Health</source>.
<year>2019</year>;<volume>109</volume>(<issue>12</issue>):<fpage>1680</fpage>&#x02013;<lpage>1686</lpage>.
<comment><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836771/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836771/</ext-link></comment>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.2105/AJPH.2019.305211</pub-id>.<pub-id pub-id-type="pmid">31536410</pub-id>
</mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><name><surname>Varkey</surname><given-names>B</given-names></name>
<article-title>Principles of clinical ethics and their application to
practice</article-title>. <source>Med Princ Pract</source>.
<year>2021</year>;<volume>30</volume>(<issue>1</issue>):<fpage>17</fpage>&#x02013;<lpage>28</lpage>.
<comment><ext-link xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923912/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923912/</ext-link></comment>.
<date-in-citation>Accessed Jan 16, 2024.</date-in-citation> doi:
<pub-id pub-id-type="doi">10.1159/000509119</pub-id>.<pub-id pub-id-type="pmid">32498071</pub-id>
</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Figure 1.</label><caption><p id="P38">Planned Parenthood of Southern New England (PPSNE) and Planned
Parenthood Great Northwest, Hawai&#x02019;i, Alaska, Indiana, Kentucky (PPGNHAIK)
Combined Samples: Missed Opportunities for AEP Prevention</p></caption><graphic xlink:href="nihms-2032263-f0001" position="float"/></fig><table-wrap position="float" id="T1"><label>Table 1.</label><caption><p id="P39">Methods of Pregnancy Prevention<sup><xref rid="TFN1" ref-type="table-fn">1</xref></sup></p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">More effective methods</th><th align="left" valign="top" rowspan="1" colspan="1">Less effective methods</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Abstinence</td><td align="left" valign="top" rowspan="1" colspan="1">Condoms</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Menopause</td><td align="left" valign="top" rowspan="1" colspan="1">Withdrawal method</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Same-sex partner</td><td align="left" valign="top" rowspan="1" colspan="1">Natural family planning</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Implant</td><td align="left" valign="top" rowspan="1" colspan="1">Spermicide</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Intrauterine Device (IUD)</td><td align="left" valign="top" rowspan="1" colspan="1">Barrier method (including diaphragm,
sponge)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sterilization (including partner)</td><td align="left" valign="top" rowspan="1" colspan="1">Emergency contraception</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Injection</td><td align="left" valign="top" rowspan="1" colspan="1">None (including &#x02018;seeking
pregnancy&#x02019;)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patch</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ring</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oral contraception pills</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lactational amenorrhea method</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>1</label><p id="P40">More effective methods of pregnancy prevention include contraception
options that are approximately 88% effective or greater in preventing
pregnancy, and often referred to as Tier 1 or Tier 2 contraception methods.
Those classified as less effective are less than 88% effective and typically
referred to as Tier 3. For the purposes of this study, non-contraception
methods, such as menopause, abstinence and having a same-sex partner are
classified as more effective pregnancy prevention methods.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2.</label><caption><p id="P41">Sample Characteristics<sup><xref rid="TFN3" ref-type="table-fn">1</xref></sup> for Planned Parenthood of Southern New England, Planned
Parenthood Great Northwest, Hawai'i, Alaska, Indiana, Kentucky, and the Combined
Health Systems Sample</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Characteristic</th><th align="center" valign="bottom" rowspan="1" colspan="1">PPSNE (<italic toggle="yes">n</italic>=5,703)</th><th align="center" valign="bottom" rowspan="1" colspan="1">PPGNHAIK (<italic toggle="yes">n</italic>=5,864)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Combined Sample
(<italic toggle="yes">n</italic>=11,567)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Age: Mean (SD)</bold>
<xref rid="TFN6" ref-type="table-fn">*</xref>
</td><td align="right" valign="top" rowspan="1" colspan="1">31.71 (7.44)</td><td align="right" valign="top" rowspan="1" colspan="1">28.97 (6.91)</td><td align="right" valign="top" rowspan="1" colspan="1">30.34 (7.18)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Female Sex</bold>
</td><td align="right" valign="top" rowspan="1" colspan="1">100.0%</td><td align="right" valign="top" rowspan="1" colspan="1">100.0%</td><td align="right" valign="top" rowspan="1" colspan="1">100%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Race</bold>
<sup>
<xref rid="TFN4" ref-type="table-fn">2</xref>
<xref rid="TFN6" ref-type="table-fn">*</xref>
</sup>
</td><td align="right" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Asian/Pacific
Islander</bold></td><td align="right" valign="top" rowspan="1" colspan="1">2.8%</td><td align="right" valign="top" rowspan="1" colspan="1">13.1%</td><td align="right" valign="top" rowspan="1" colspan="1">8.0%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Black</bold></td><td align="right" valign="top" rowspan="1" colspan="1">20.8%</td><td align="right" valign="top" rowspan="1" colspan="1">7.7%</td><td align="right" valign="top" rowspan="1" colspan="1">14.2%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Alaska Native/American
Indian</bold></td><td align="right" valign="top" rowspan="1" colspan="1">0.5%</td><td align="right" valign="top" rowspan="1" colspan="1">1.7%</td><td align="right" valign="top" rowspan="1" colspan="1">1.1%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>White</bold></td><td align="right" valign="top" rowspan="1" colspan="1">56.1%</td><td align="right" valign="top" rowspan="1" colspan="1">Hispanic: 2.1%<break/>Not Hispanic:
65.5%</td><td align="right" valign="top" rowspan="1" colspan="1">61.9%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Other/Unknown</bold></td><td align="right" valign="top" rowspan="1" colspan="1">19.9%</td><td align="right" valign="top" rowspan="1" colspan="1">9.8%</td><td align="right" valign="top" rowspan="1" colspan="1">14.8%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Hispanic Ethnicity</bold>
<sup>
<xref rid="TFN4" ref-type="table-fn">2</xref>
<xref rid="TFN6" ref-type="table-fn">*</xref>
</sup>
</td><td align="right" valign="top" rowspan="1" colspan="1">25.0%</td><td align="right" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Primary Insurance Type</bold>
</td><td align="right" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Commercial</bold></td><td align="right" valign="top" rowspan="1" colspan="1">44.1%</td><td align="right" valign="top" rowspan="1" colspan="1">54.7%</td><td align="right" valign="top" rowspan="1" colspan="1">49.5%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Public</bold></td><td align="right" valign="top" rowspan="1" colspan="1">42.6%</td><td align="right" valign="top" rowspan="1" colspan="1">45.3%</td><td align="right" valign="top" rowspan="1" colspan="1">44.0%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Self-pay/Uninsured</bold></td><td align="right" valign="top" rowspan="1" colspan="1">13.3%</td><td align="right" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Method of Pregnancy
Prevention</bold>
<xref rid="TFN6" ref-type="table-fn">*</xref>
</td><td align="right" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>More effective</bold></td><td align="right" valign="top" rowspan="1" colspan="1">70.2%</td><td align="right" valign="top" rowspan="1" colspan="1">82.0%</td><td align="right" valign="top" rowspan="1" colspan="1">76.2%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Less effective</bold></td><td align="right" valign="top" rowspan="1" colspan="1">29.8%</td><td align="right" valign="top" rowspan="1" colspan="1">18.0%</td><td align="right" valign="top" rowspan="1" colspan="1">23.8%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Alcohol Risk Level</bold>
<xref rid="TFN6" ref-type="table-fn">*</xref>
</td><td align="right" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Abstinent (no risk)</bold></td><td align="right" valign="top" rowspan="1" colspan="1">17.7%</td><td align="right" valign="top" rowspan="1" colspan="1">21.2%</td><td align="right" valign="top" rowspan="1" colspan="1">19.5%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Low-risk (USAUDIT Score:
1&#x02013;6)</bold></td><td align="right" valign="top" rowspan="1" colspan="1">64.1%</td><td align="right" valign="top" rowspan="1" colspan="1">68.0%</td><td align="right" valign="top" rowspan="1" colspan="1">66.1%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Moderate-risk (USAUDIT Score:
7&#x02013;24)</bold></td><td align="right" valign="top" rowspan="1" colspan="1">17.8%</td><td align="right" valign="top" rowspan="1" colspan="1">10.6%</td><td align="right" valign="top" rowspan="1" colspan="1">14.1%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>High-risk (USAUDIT Score:
25+)</bold></td><td align="right" valign="top" rowspan="1" colspan="1">0.4%</td><td align="right" valign="top" rowspan="1" colspan="1">0.3%</td><td align="right" valign="top" rowspan="1" colspan="1">0.3%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Other Substance Use</bold>
<sup>
<xref rid="TFN5" ref-type="table-fn">3</xref>
<xref rid="TFN6" ref-type="table-fn">*</xref>
</sup>
</td><td align="right" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Marijuana</bold></td><td align="right" valign="top" rowspan="1" colspan="1">32.4%</td><td align="right" valign="top" rowspan="1" colspan="1">23.6%</td><td align="right" valign="top" rowspan="1" colspan="1">27.9%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Cocaine/crack</bold></td><td align="right" valign="top" rowspan="1" colspan="1">0.9%</td><td align="right" valign="top" rowspan="1" colspan="1">1.1%</td><td align="right" valign="top" rowspan="1" colspan="1">1.0%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Amphetamine type stimulants
(methamphetamine, prescription stimulants)</bold></td><td align="right" valign="top" rowspan="1" colspan="1">1.5%</td><td align="right" valign="top" rowspan="1" colspan="1">0.4%</td><td align="right" valign="top" rowspan="1" colspan="1">0.9%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Sedatives/sleeping
pills</bold></td><td align="right" valign="top" rowspan="1" colspan="1">2.6%</td><td align="right" valign="top" rowspan="1" colspan="1">0.0%</td><td align="right" valign="top" rowspan="1" colspan="1">1.3%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Prescription
opioids/heroin</bold></td><td align="right" valign="top" rowspan="1" colspan="1">1.5%</td><td align="right" valign="top" rowspan="1" colspan="1">0.2%</td><td align="right" valign="top" rowspan="1" colspan="1">0.8%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Other substances (LSD,
psilocybin, ketamine, MDMA, OTC cough medicine)</bold></td><td align="right" valign="top" rowspan="1" colspan="1">0.2%</td><td align="right" valign="top" rowspan="1" colspan="1">0.3%</td><td align="right" valign="top" rowspan="1" colspan="1">0.3%</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p id="P42">Legend. PPSNE: Planned Parenthood of Southern New England; PPGNHAIK:
Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana, Kentucky; SD:
standard deviation; USAUDIT: Alcohol Use Disorders Identification Test, US
version; LSD: lysergic acid diethylamide; MDMA:
methylenedioxy-methylamphetamine; OTC: over the counter; ASSIST-FC: Alcohol
Smoking and Substance Involvement Screening Test-Frequency and Concern;
DAST-10: Drug Abuse Screening Test</p></fn><fn id="TFN3"><label>1</label><p id="P43">Sample comprises data for 18&#x02013;49-year-old females screened for
alcohol use during a preventive visit from 1/1/2021&#x02013;12/31/2021;</p></fn><fn id="TFN4"><label>2</label><p id="P44">Race and Hispanic Ethnicity are not mutually exclusive;</p></fn><fn id="TFN5"><label>3</label><p id="P45">Indicates current use as defined by the ASSIST-FC (PPSNE) or the
DAST-10 (PPGNHAIK) screening tools. Other Substance Use categories are not
mutually exclusive;</p></fn><fn id="TFN6"><label>*</label><p id="P46">Significant differences between health systems occur for mean age,
race (White vs. all other races), method of pregnancy prevention, alcohol
risk level (low risk vs. moderate risk and abstinent vs. moderate risk), and
other substance use (marijuana vs. all other substances). All tests are
significant at <italic toggle="yes">p</italic>&#x0003c;.001</p></fn></table-wrap-foot></table-wrap></floats-group></article>